The revenue share of generic pharmaceuticals in Norway increased annually during the period from 2013 to 2021. In 2021, the share of generic pharmaceutical had increased to 55.4 percent of total pharmaceutical sales (based on defined daily dose).
Market share of generic pharmaceuticals in Norway from 2013 to 2021
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Legemiddelindustrien. (March 14, 2022). Market share of generic pharmaceuticals in Norway from 2013 to 2021 [Graph]. In Statista. Retrieved November 22, 2024, from https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/
Legemiddelindustrien. "Market share of generic pharmaceuticals in Norway from 2013 to 2021." Chart. March 14, 2022. Statista. Accessed November 22, 2024. https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/
Legemiddelindustrien. (2022). Market share of generic pharmaceuticals in Norway from 2013 to 2021. Statista. Statista Inc.. Accessed: November 22, 2024. https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/
Legemiddelindustrien. "Market Share of Generic Pharmaceuticals in Norway from 2013 to 2021." Statista, Statista Inc., 14 Mar 2022, https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/
Legemiddelindustrien, Market share of generic pharmaceuticals in Norway from 2013 to 2021 Statista, https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/ (last visited November 22, 2024)
Market share of generic pharmaceuticals in Norway from 2013 to 2021 [Graph], Legemiddelindustrien, March 14, 2022. [Online]. Available: https://www.statista.com/statistics/945519/turnover-share-of-generic-pharmaceuticals-in-norway/